Skip to main content

WPI 2234 Pill - orange & yellow capsule/oblong, 19mm

Pill with imprint WPI 2234 is Orange & Yellow, Capsule/Oblong and has been identified as Tetracycline Hydrochloride 250 mg. It is supplied by Watson Pharmaceuticals, Inc.

Tetracycline is used in the treatment of Acne; Bladder Infection; Bacterial Infection; Bronchitis; Nongonococcal Urethritis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Tetracycline 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2234

Tetracycline hydrochloride 250 mg WPI 2234

Tetracycline Hydrochloride

Imprint
WPI 2234
Strength
250 mg
Color
Orange & Yellow
Size
19.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Tetracyclines
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals, Inc.
National Drug Code (NDC)
00591-2234 (Discontinued)
Inactive Ingredients
lactose, magnesium stearate, sodium lauryl sulfate, D&C Yellow No. 10, FD&C Yellow No. 6, gelatin, titanium dioxide, benzyl alcohol, butylparaben, D&C Red No. 22, edetate calcium disodium, methylparaben, propylparaben, silicon dioxide, sodium propionate, shellac, ferrosoferric oxide, dimethicone, water, ethylene glycol monoethyl ether, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, soya lecithin, butyl alcohol, alcohol, aluminum oxide

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer